Delivery Order SPE2DB24D2205-SPE2DB25FEFQT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,881.36 to AmerisourceBergen Drug Corp for the supply of Xolair 150 mg/ml syringes, with an ultimate completion date of August 25, 2025. This competitive award, issued on August 4, 2025, utilizes firm fixed pricing and carries no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order valued at $21,610.20 to AmerisourceBergen Drug Corp for XOLAIR 150 mg/mL syringes on August 13, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract fulfilling pharmaceutical supply requirements for federal medical procurement. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,440.70 for Xolair 150 mg/ml syringes, with an ultimate completion date of May 14, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing under a delivery order contract type. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,440.70 to AmerisourceBergen Drug Corp for Xolair 150 mg/ml syringes, with an ultimate completion date of August 12, 2025. This is a firm fixed price, non-set-aside contract awarded on July 22, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $4,322.04 to AmerisourceBergen Drug Corp for XOLAIR 150 mg/ml syringes on July 18, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract is for performance at AmerisourceBergen's corporate headquarters location in...
- The Defense Logistics Agency awarded a $3,241.54 delivery order to AmerisourceBergen Drug Corp for Xolair 150 mg/ml syringes, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a direct procurement of pharmaceutical supplies for federal medical needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,161.02 to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Xolair 150 mg/ml syringes. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 11, 2025. The contract is to be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Xolair 150 mg/mL syringes, valued at $10,805.10. This is a firm fixed-price delivery order with a completion date of August 20, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's proven capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $34,576.32 to supply Xolair 150 mg/mL syringes, with a completion date of July 14, 2025. This competitive award uses firm fixed pricing and carries no set-aside designation. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs....
- The Defense Logistics Agency awarded a Delivery Order valued at $1,440.70 to AmerisourceBergen Drug Corp for the supply of Xolair 150 mg/ml syringes, with an ultimate completion date of September 9, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under a larger indefinite delivery contract vehicle. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFQTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xolair 150 mg/ml syringes, valued at $2,161.02, with an ultimate completion date of August 21, 2025. This is a firm fixed price, non-set-aside delivery order issued on July 31, 2025, under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen Drug Corp's substantial $999.999 billion IDC with DLA Troop Support Medical (designated SPE2DX), which runs through December 2026. The indefinite delivery contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains for customers including the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 7/31/25 |